17
Cellular and molecular characterization of the pirfenidone effects on an hepatocarcinogésis experimental model
Read
876
Timeswas read the article
331
Total PDF
545
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 16 | 9 | 25 |
| 2025 11 | 23 | 22 | 45 |
| 2025 10 | 18 | 11 | 29 |
| 2025 9 | 16 | 12 | 28 |
| 2025 8 | 23 | 15 | 38 |
| 2025 7 | 34 | 8 | 42 |
| 2025 6 | 15 | 2 | 17 |
| 2025 5 | 23 | 1 | 24 |
| 2025 4 | 12 | 1 | 13 |
| 2025 3 | 20 | 5 | 25 |
| 2025 2 | 8 | 5 | 13 |
| 2025 1 | 14 | 2 | 16 |
| 2024 12 | 10 | 2 | 12 |
| 2024 11 | 26 | 6 | 32 |
| 2024 10 | 10 | 2 | 12 |
| 2024 9 | 7 | 2 | 9 |
| 2024 8 | 3 | 1 | 4 |
| 2024 7 | 5 | 1 | 6 |
| 2024 6 | 3 | 1 | 4 |
| 2024 5 | 8 | 2 | 10 |
| 2024 4 | 10 | 3 | 13 |
| 2024 3 | 8 | 2 | 10 |
| 2024 2 | 6 | 2 | 8 |
| 2024 1 | 8 | 3 | 11 |
| 2023 12 | 3 | 2 | 5 |
| 2023 11 | 6 | 3 | 9 |
| 2023 10 | 8 | 7 | 15 |
| 2023 9 | 3 | 3 | 6 |
| 2023 8 | 5 | 1 | 6 |
| 2023 7 | 3 | 33 | 36 |
| 2023 6 | 6 | 6 | 12 |
| 2023 5 | 8 | 1 | 9 |
| 2023 4 | 5 | 0 | 5 |
| 2023 3 | 4 | 6 | 10 |
| 2023 2 | 5 | 2 | 7 |
| 2023 1 | 7 | 3 | 10 |
| 2022 12 | 5 | 5 | 10 |
| 2022 11 | 4 | 5 | 9 |
| 2022 10 | 4 | 5 | 9 |
| 2022 9 | 8 | 4 | 12 |
| 2022 8 | 7 | 7 | 14 |
| 2022 7 | 8 | 7 | 15 |
| 2022 6 | 11 | 7 | 18 |
| 2022 5 | 5 | 5 | 10 |
| 2022 4 | 11 | 7 | 18 |
| 2022 3 | 8 | 9 | 17 |
| 2022 2 | 9 | 5 | 14 |
| 2022 1 | 6 | 6 | 12 |
| 2021 12 | 11 | 13 | 24 |
| 2021 11 | 5 | 10 | 15 |
| 2021 10 | 4 | 6 | 10 |
| 2021 9 | 7 | 4 | 11 |
| 2021 8 | 2 | 0 | 2 |
| 2021 7 | 5 | 6 | 11 |
| 2021 6 | 3 | 5 | 8 |
| 2021 5 | 9 | 8 | 17 |
| 2021 4 | 10 | 6 | 16 |
| 2021 3 | 1 | 9 | 10 |
| 2021 2 | 3 | 2 | 5 |
| 2021 1 | 3 | 2 | 5 |
| 2020 12 | 1 | 0 | 1 |
| 2020 9 | 6 | 1 | 7 |
Show all
